Invivyd
About:
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Website: https://invivyd.com/
Twitter/X: invivyd
Top Investors: OrbiMed, RA Capital Management, Fidelity, Google Ventures, Foresite Capital
Description:
Invivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2.
Total Funding Amount:
$466M
Estimated Revenue Range:
$1B to $10B
Headquarters Location:
Waltham, Massachusetts, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)invivyd.com
Founders:
Laura Walker, Tillman Gerngross
Number of Employees:
51-100
Last Funding Date:
2021-04-19
IPO Status:
Public
© 2025 bioDAO.ai